Padilla ML - Search Results

1

Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphavbeta3 integrin.

Dickerson EB, Akhtar N, Steinberg H, Wang ZY, Lindstrom MJ, Padilla ML, Auerbach R, Helfand SC. Dickerson EB, et al. Among authors: padilla ml. Mol Cancer Res. 2004 Dec;2(12):663-73. Mol Cancer Res. 2004. PMID: 15634755

2

Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.

Akhtar N, Padilla ML, Dickerson EB, Steinberg H, Breen M, Auerbach R, Helfand SC. Akhtar N, et al. Among authors: padilla ml. Neoplasia. 2004 Mar-Apr;6(2):106-16. doi: 10.1593/neo.03334. Neoplasia. 2004. PMID: 15140399 Free PMC article.

3

GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.

Helfand SC, Dickerson EB, Munson KL, Padilla ML. Helfand SC, et al. Among authors: padilla ml. Cancer Res. 1999 Jul 1;59(13):3119-27. Cancer Res. 1999. PMID: 10397254

4

Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer.

Dickerson EB, Fosmire S, Padilla ML, Modiano JF, Helfand SC. Dickerson EB, et al. Among authors: padilla ml. J Immunother. 2002 Jan-Feb;25(1):36-45. doi: 10.1097/00002371-200201000-00004. J Immunother. 2002. PMID: 11924909

5

Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs.

Phillips BS, Padilla ML, Dickerson EB, Lindstrom MJ, Helfand SC. Phillips BS, et al. Among authors: padilla ml. Vet Immunol Immunopathol. 1999 Sep 20;70(3-4):189-201. doi: 10.1016/s0165-2427(99)00068-9. Vet Immunol Immunopathol. 1999. PMID: 10507361

6

Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium.

Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J, Breen M, Helfand SC, Modiano JF. Fosmire SP, et al. Lab Invest. 2004 May;84(5):562-72. doi: 10.1038/labinvest.3700080. Lab Invest. 2004. PMID: 15064773 Free article.

7

Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis.

Hershey AE, Dubielzig RR, Padilla ML, Helfand SC. Hershey AE, et al. Among authors: padilla ml. Vet Pathol. 2005 Nov;42(6):805-11. doi: 10.1354/vp.42-6-805. Vet Pathol. 2005. PMID: 16301577

8

Enhancing antimelanoma immune responses through apoptosis.

Bianco SR, Sun J, Fosmire SP, Hance K, Padilla ML, Ritt MG, Getzy DM, Duke RC, Withrow SJ, Lana S, Matthiesen DT, Dow SW, Bellgrau D, Cutter GR, Helfand SC, Modiano JF. Bianco SR, et al. Among authors: padilla ml. Cancer Gene Ther. 2003 Sep;10(9):726-36. doi: 10.1038/sj.cgt.7700625. Cancer Gene Ther. 2003. PMID: 12944992 Clinical Trial.

9

Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies.

Lund JR, Paoloni M, Kurzman I, Padilla M, Argyle DJ. Lund JR, et al. Vet J. 2008 Aug;177(2):192-7. doi: 10.1016/j.tvjl.2007.09.015. Epub 2007 Nov 5. Vet J. 2008. PMID: 17981480

10

Evaluation of the gene for inducible nitric oxide synthase as a radiosensitizer under hypoxic and oxic conditions.

Turek M, Padilla M, Argyle DJ. Turek M, et al. Vet Comp Oncol. 2007 Dec;5(4):250-5. doi: 10.1111/j.1476-5829.2007.00138.x. Vet Comp Oncol. 2007. PMID: 19754783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters